These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17147300)

  • 1. [Primary prevention, aspirin and diabetes].
    Balaguer Vintró I
    Rev Esp Salud Publica; 2006; 80(6):609-12. PubMed ID: 17147300
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Ajjan RA
    Diab Vasc Dis Res; 2012 Oct; 9(4):243-4. PubMed ID: 22942227
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?].
    Benhamou Y; Lévesque H
    Rev Med Interne; 2009 Dec; 30(12):1001-3. PubMed ID: 19833416
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-platelet treatment for all diabetic patients?].
    Torres Baile JL; Ortega Sánchez G
    Aten Primaria; 2010 Apr; 42(4):241-2. PubMed ID: 19628306
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin use in patients with diabetes mellitus].
    Barquero Romero J; Masero Carretero A; Pérez Miranda M
    Med Clin (Barc); 2004 Jul; 123(6):237; author reply 239. PubMed ID: 15282082
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aspirin use in patients with diabetes mellitus].
    Diogène E; Agustí A
    Med Clin (Barc); 2004 Jul; 123(6):237-8; author reply 239. PubMed ID: 15282083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspirin use in patients with diabetes mellitus].
    González-Clemente JM; Barahona MJ; Giménez-Pérez G; Mauricio D
    Med Clin (Barc); 2004 Jul; 123(6):238-9; author reply 239. PubMed ID: 15282084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].
    Legrand DA; Scheen AJ
    Rev Med Liege; 2007 Oct; 62(10):610-5. PubMed ID: 18069572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin as primary prevention for diabetic patients].
    Fumeaux D; Becerra ME; Philippe J; Louis-Simonet M
    Rev Med Suisse; 2010 Feb; 6(234):244-8. PubMed ID: 20334083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspirin use in patients with diabetes mellitus].
    Sicras Mainar A; Ruiz Riera R; Frías Garrido X; Navarro Artieda R
    Med Clin (Barc); 2004 Jul; 123(6):237; author reply 239. PubMed ID: 15282081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aspirin for the primary prevention of cardiovascular diseases in diabetic patients. A review of currently available tests].
    Maciá Bobes C; Ronzón Fernández A; Fernández García E
    Rev Esp Salud Publica; 2006; 80(6):613-20. PubMed ID: 17147301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    Diabetes Care; 2010 Jun; 33(6):1395-402. PubMed ID: 20508233
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspirin for primary prevention of cardiovascular diseases in diabetic patients: focus on gender difference and insulin resistance].
    Legrand DA; Scheen AJ
    Rev Med Liege; 2006 Oct; 61(10):682-90. PubMed ID: 17209500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 20. Trials of primary prevention of cardiovascular events using aspirin.
    Kappagoda CT; Amsterdam EA
    Am J Cardiol; 2011 Oct; 108(8):1198-200. PubMed ID: 21985953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.